<DOC>
	<DOC>NCT00481962</DOC>
	<brief_summary>The main goals of the study are: Assessment of Tygacil's cost-effectiveness; Process cost analysis from a hospital perspective (including length of stay, treatment costs, side effect management costs, costs of monitoring, costs of diagnostic procedures, cost of care (TISS 10 score etc.); Efficacy of Tygacil under usual care conditions (cure rate).</brief_summary>
	<brief_title>Health Economic Assessment of TygacilÂ® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)</brief_title>
	<detailed_description />
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<criteria>Diagnosis of secondary peritonitis Treatment in an ICU Patient age &gt;18 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>